AstraZeneca PLC
AZNCF · OTC
Bulios Fair Price
$112.16
40.9% downside
Current Price
$189.9
According to Bulios Fair Price, AZNCF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
AstraZeneca PLC is a British-Swedish pharmaceutical company headquartered in Cambridge, United Kingdom. Founded in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group, AstraZeneca focuses on the research, development, and production of innovative drugs, primarily in oncology, cardiovascular diseases, respiratory conditions, immunology, and infectious diseases. The company is recognized for its advancements in biotechnology and its commitment to long-term public health. AstraZeneca operates globally and has made significant contributions to drug development, including vaccines, notably in the fight against COVID-19.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Pascal Claude Roland Soriot
Employees
94,300
Headquarters
Cambridge